President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut costs associated ...

Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his skin. Then came the pain and swelling in the joints of […] ...

Using a copay card has gotten trickier as insurers push back. First, patients need to understand whether there is an annual dollar or time limit on the card and how it works with their insurance.

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. There is also currently no ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

Jan 27 (Reuters) - The U.S. government on ‌Tuesday named the 15 new drugs targeted ‌for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis ...

Another frontier of GLP-1 therapy could be opening up. Clinical trial data out today finds that tirzepatide (the active ingredient in the GLP-1 weight loss drug Zepbound) can be an effective add-on ...

Patients given a combination of Eli Lilly & Co.’s weight-loss shot Zepbound and arthritis drug Taltz saw a greater improvement in tender and swollen joints compared to those on Taltz alone, a new ...

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but their relative effects on pain, versus inflammation, are less ...

Rheumatoid arthritis (RA) is an autoimmune disease that causes swelling, stiffness, and inflammation in the joints as the immune system attacks its own body’s tissues. And while diet alone can’t treat ...